IGC Pharma, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q2 2010 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
IGC Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2010 to Q2 2025.
- IGC Pharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2025 was $580K.
- IGC Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$442K, a 39.4% decline from 2023.
- IGC Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$317K, a 34.9% decline from 2022.
- IGC Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$235K, a 68.3% increase from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)